GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (BOM:500288) » Definitions » Change In Receivables

Morepen Laboratories (BOM:500288) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Morepen Laboratories Change In Receivables?

Morepen Laboratories's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Morepen Laboratories's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Morepen Laboratories's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-1,307 Mil. It means Morepen Laboratories's Accounts Receivable increased by ₹1,307 Mil from Mar. 2024 to Mar. 2025 .

Morepen Laboratories's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹3,248 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Morepen Laboratories's Days Sales Outstanding for the three months ended in Mar. 2025 was 63.61.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Morepen Laboratories's liquidation value for the three months ended in Mar. 2025 was ₹-592 Mil.


Morepen Laboratories Change In Receivables Historical Data

The historical data trend for Morepen Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories Change In Receivables Chart

Morepen Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -900.17 -1,325.66 -629.68 -1,178.92 -1,307.14

Morepen Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Morepen Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Morepen Laboratories  (BOM:500288) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Morepen Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3247.634/4658.533*91
=63.61

2. In Ben Graham's calculation of liquidation value, Morepen Laboratories's accounts receivable are only considered to be worth 75% of book value:

Morepen Laboratories's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1384.236-5911.418+0.75 * 3247.634+0.5 * 2999.65
=-592

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Morepen Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories Business Description

Traded in Other Exchanges
Address
Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.

Morepen Laboratories Headlines

No Headlines